KORU Medical Systems, Inc. - KRMD
About Gravity Analytica
Recent News
- 01.29.2026 - KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO® (rozanolixizumab-noli), Expanding Label for FreedomEDGE® Infusion System
- 01.12.2026 - KORU Medical Systems Reports Preliminary Q4 and Full Year 2025 Results; Achieves Record Revenue and Full Year Positive Operating Cash Flow
- 01.05.2026 - KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- 12.30.2025 - KORU Medical Systems Announces 510(k) Submission for Clearance of the FreedomEDGE® System with a Commercialized Oncology Biologic
- 12.16.2025 - KORU Medical Systems, Inc. Appoints Eric Schiller as Chief Technology Officer
- 11.17.2025 - KORU Medical Systems to Present Promising Results on the Use of the FreedomEDGE® Syringe Infusion System in Infusion Centers at ESID/EHA/SIOPE Focused Symposium 2025
Recent Filings
- 01.21.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
- 01.15.2026 - 3 Initial statement of beneficial ownership of securities
- 01.15.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.12.2026 - 8-K Current report
- 01.06.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.05.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.05.2026 - S-8 Securities to be offered to employees in employee benefit plans
- 01.02.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.02.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.02.2026 - 4 Statement of changes in beneficial ownership of securities